Achieve Life Sciences (ACHV) EPS (Diluted) (2010 - 2018)
Powered by 
Analysis
Achieve Life Sciences (ACHV) EPS (Diluted) (2010 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.15 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -547.33 |
| Sep 30, 2018 | -487.58 |
| Jun 30, 2018 | -419.56 |
| Mar 31, 2018 | -454.78 |
| Dec 31, 2017 | -562.83 |
| Sep 30, 2017 | -1,414.60 |
| Jun 30, 2017 | -24.98 |
| Mar 31, 2017 | -49.51 |
| Dec 31, 2016 | -92.25 |
| Sep 30, 2016 | -60.95 |
| Dec 31, 2015 | -185.85 |
| Dec 31, 2012 | -5,732.58 |
| Sep 30, 2012 | 890.90 |
| Jun 30, 2012 | 923.33 |
| Mar 31, 2012 | -1,502.74 |
| Dec 31, 2011 | -4,332.31 |
| Sep 30, 2011 | -979.19 |
| Jun 30, 2011 | 1,478.38 |
| Mar 31, 2011 | -1,037.83 |
| Dec 31, 2010 | -954.33 |